Retinoic acid and/or arsenic trioxide cure patients with acute promyelocytic leukemia (APL) through eradicating APL-initiating cells by activating the p53 and promyelocytic leukemia proteins to induce senescence but not apoptosis of leukemia-initiating cells15. Here, TP53 is linked to leukemia.